WO2016130835A1 - Appareil, système et procédé de stimulation nerveuse sélective et non invasive des mammifères et des humains - Google Patents
Appareil, système et procédé de stimulation nerveuse sélective et non invasive des mammifères et des humains Download PDFInfo
- Publication number
- WO2016130835A1 WO2016130835A1 PCT/US2016/017597 US2016017597W WO2016130835A1 WO 2016130835 A1 WO2016130835 A1 WO 2016130835A1 US 2016017597 W US2016017597 W US 2016017597W WO 2016130835 A1 WO2016130835 A1 WO 2016130835A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nerve
- electric field
- target
- electrodes
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36031—Control systems using physiological parameters for adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36178—Burst or pulse train parameters
Definitions
- Mammalian and human nerves control organs and muscles. Artificially stimulating the nerves elicits desired organ and muscle responses. Accessing the nerves to selectively control these responses from outside the body, without invasive implants or needles penetrating the dermis, muscle or fat tissue is desired.
- a Topical Nerve Stimulator and Sensor (TNSS) device described in the related United States Patent Application Serial No. PCT/US 14/40240 filed May 30, 2014 is used to stimulate nerves.
- a TNSS may apply electrode generated electric field(s) in a low frequency to dermis in the proximity of a nerve, and typically applies such a field in the magnitude of kilohertz (KHz).
- KHz kilohertz
- the TNSS also includes hardware and logic for high frequency (GHz) communication to mobile devices.
- a wireless system including a TNSS device is described herein. Its components, features and performance characteristics are set forth in the following technical description. Advantages of a wireless TNSS system over existing transcutaneous electrical nerve stimulation devices are:
- multiple electrodes of a TNSS can form an array to shape an electric field in the tissues
- multiple TNSS devices can form an array to shape an electric field in the tissues; [0008] multiple TNSS devices can stimulate multiple structures, coordinated by a smartphone;
- transmitting antenna of TNSS device can focus beam of electromagnetic energy within tissues in short bursts to activate nerves directly without implanted devices;
- TNSS devices are expected to have service lifetimes of days to weeks and their disposability places less demand on power sources and battery
- multiple TNSS devices can form a network with each other, with remote controllers, with other devices, with the internet and with other users;
- a nerve cell normally has a voltage across the cell membrane of 70 millivolts with the interior of the cell at a negative voltage with respect to the exterior of the cell. This is known as the resting potential and it is normally maintained by metabolic reactions which maintain different
- Ions can be actively "pumped” across the cell membrane through ion channels in the membrane that are selective for different types of ion, suc as sodium and potassium.
- the channels are voltage sensitive and can be opened or closed depending on the voltage across the membrane.
- An electric field produced within the tissues by a stimulator can change the normal resting voltage across the membrane, either increasing or decreasing the voltage from its resting voltage.
- a decrease in voltage across the cell membrane to about 55 millivolts opens certain ion channels, allowing ions to flow through the membrane in a self-catalyzing but self-limited process which results in a transient decrease of the trans membrane potential to zero, and even positive, known as depolarization followed by a rapid restoration of the resting potential as a result of active pumping of ions across the membrane to restore the resting situation which is known as repolarization .
- This transient change of voltage is known as an action potential and it typically spreads over the entire surface of the cell. If the shape of the cell is such that it has a long extension known as an axon, the action potential spreads along the length of the axon. Axons that have insulating myelin sheaths propagate action potentials at much higher speeds than those axons without myelin sheaths or with damaged myelin sheaths.
- the action potential reaches a junction, known as a synapse, with another nerve cell
- the transient change in membrane voltage results in the release of chemicals known as neurotransmitters that can initiate an action potential in the other cell.
- This provides a means of rapid electrical communication between cells, analogous to passing a digital pulse from one cell to another.
- the action potential reaches a synapse with a muscle cell it can initiate an action potential that spreads over the surface of the muscle cell.
- This voltage change across the membrane of the muscle cell opens ion channels in the membrane that allow ions such as sodium, potassium and calcium to flow across the membrane, and can result in contraction of the muscle cell.
- the voltage across the membrane of a cell can be changed by creating an electric field in the tissues with a stimulator. It is important to note that action potentials are created within the mammalian nervous system by the brain, the sensory nervous system or other internal means. These action potentials travel along the body's nerve "highways".
- the TNSS creates an action potential through an externally applied electric field from outside the body. This is very different than how action potentials are naturally created within the body.
- electric fields capable of causing action potentials can be generated by electronic stimulators connected to electrodes that are implanted surgically in close proximity to the target nerves.
- electronic devices located on the surface of the skin.
- Such devices typically use square wave pulse trains of the form shown in Figure 3.
- Such devices may be used instead of implants and/or with implants such as reflectors, conductors, refractors, or markers for tagging target nerves and the like, so as to shape electric fields to enhance nerve targeting and/or selectivity.
- the amplitude of the pulses, A, applied to the skin may vary between 1 and 100 Volts, pulse width, t, between 100 microseconds and 10 milliseconds, duty cycle (t/T) between 0.1% and 50%, the frequency of the pulses within a group between 1 and 100/sec, and the number of pulses per group, n, between 1 and several hundred.
- pulses applied to the skin will have an amplitude of up to 60 volts, a pulse width of 250 microseconds and a frequency of 20 per second, resulting in a duty cycle of 0.5%.
- balanced-charge biphasic pulses will be used to avoid net current flow.
- these pul ses may be symmetrical, with the shape of the first part of the pulse similar to that of the second part of the pulse, or asymmetrical, in which the second part of the pulse has lower amplitude and a longer pulse width in order to avoid canceling the stimulatory effect of the first part of the pulse.
- the location and magnitude of the electric potential applied to the tissues by electrodes provides a method of shaping the electrical field. For example, applying two electrodes to the skin, one at a positive electrical potential with respect to the other, can produce a field in the underlying tissues such as that shown in the cross-sectional diagram, Figure 5.
- the diagram in Figure 5 assumes homogeneous tissue.
- the voltage gradient is highest close to the electrodes and lower at a distance from the electrodes. Nerves are more likely to be activated close to the electrodes than at a distance. For a given voltage gradient, nerves of large diameter are more likely to be activated than nerves of smaller diameter. Nerves whose long axis is aligned with the voltage gradient are more likely to be activated than nerves whose long axis is at right angles to the voltage gradient.
- FIG. 6 applying similar electrodes to a part of the body in which there are two layers of tissue of different electrical resistivity, such as fat and muscle, can produce a field such as that shown in Figure 6. Layers of different tissue may act to refract and direct energy waves and be used for beam aiming and steering. An individual's tissue parameters may be measured and used to
- an important factor in the formation of electric fields used to create action potentials in nerve cells is the medium through which the electric fields must penetrate.
- this medium consists of various types of tissue including bone, fat, muscle, and skin.
- Each of these tissues possesses different electrical resistivity or conductivity and different capacitance and these properties are anisotropic. They are not uniform in all directions within the tissues. For example, an axon has lower electrical resistivity along its axis than
- the pulse trains can differ from one another indicated by A, t/T, n, and f as well as have different phase relationships between the pulse trains.
- combinations of electrodes can be utilized ranging from simple dipoles, to quadripoles, to linear arrangements, to approximately circular configurations, to produce desired electric fields within tissues.
- Electrodes to a part of the body with complex tissue geometry will thus result in an electric field of a complex shape.
- the interaction of electrode arrangement and tissue geometry can be modeled using Finite Element Modeling, which is a mathematical method of dividing the tissues into many small elements in order to calculate the shape of a complex electric field. This can be used to design an electric field of a desired shape and orientation to a particular nerve.
- High frequency techniques known for modifying an electric field may not apply to application of electric fields by TNSSs because they use low frequencies.
- the present system uses beam selection to move or shift or shape an electric field, also described as field steering or field shaping, by activating different electrodes, such as from an array of electrodes, to move the field. Selecting different combinations of electrodes from an array may result in beam or field steering.
- a particular combination of electrodes may shape a beam and/or change the direction of a beam by steering. This may shape the electric field to reach a target nerve selected for stimulation.
- Electrodes to be implanted surgically on or near nerves.
- Using electrodes on the surface of the skin to focus activation selectively on nerves deep in the tissues has many advantages. These include avoidance of surgery, avoidance of the cost of developing complex implants and gaining regulatory approval for them, and avoidance of the risks of long-term implants.
- the features of the electric field that determine whether a nerve will be activated to produce an action potential can be modeled mathematically by the Activating Function described by attay (Rattay F. The basic mechanism for the electrical stimulation of the nervous system. Neuroscience Vol. 89, No. 2, pp. 335- 346, 1999).
- the electric field can produce a voltage, or extracellular potential, within the tissues that varies along the length of a nerve. If the voltage is proportional to distance along the nerve, the first order spatial derivative will be constant and the second order spatial derivative will be zero. If the voltage is not proportional to distance along the nerve, the first order spatial derivative will not be constant and the second order spatial derivative will not be zero.
- the Activating Function is proportional to the second-order spatial derivative of the extracellular potential along the nerve. If it is sufficiently greater than zero at a given point it predicts whether the electric field will produce an action potential in the nerve at that point. This prediction may be input to a nerve signature.
- the nerve to be activated must be accurately selected. This selectivity may be improved by using the system described herein, and described herein as a nerve signature, in several ways, as follows:
- the TNSS 934 human and mammalian interface and its method of operation and supporting system are managed by a Master Control Program (MCP) 910 represented in function format as block diagrams. It provides the logic for the nerve stimulator system.
- MCP Master Control Program
- the primary responsibility of the MCP 910 is to coordinate the activities and communications among the various control programs, the Data Manager 920, the User 932, and the external ecosystem and to execute the appropriate response algorithms in each situation.
- the MCP 910 accomplishes electric field shaping and/or beam steering by providing an electrode activation pattern to the TNSS device 934 to selectively stimulate a target nerve.
- the MCP 910 upon notification by the Communications Controller 930 of an external event or request, the MCP 910 is responsible for executing the appropriate response, working with the Data Manager 920 to formulate the correct response and actions. It integrates data from various sources such as Sensors 938 and external inputs such as TNSS devices 934, and applies the correct security and privacy policies, such as encryption and HIPAA required protocols. It will also manage the User Interface (UI) 912 and the various Application Program Interfaces (APIs) 914 that provide access to external programs.
- UI User Interface
- APIs Application Program Interfaces
- the MCP is also responsible for effectively managing power
- TNSS device consumption by the TNSS device through a combination of software algorithms and hardware components that may include, among other things: computing, communications, and stimulating electronics, antenna, electrodes, sensors, and power sources in the form of conventional or printed batteries.
- the communications controller is responsible for receiving inputs from the User 932, from a plurality of TNSS devices 934, and from 3rd party apps 936 via communications sources such as Internet or cellular networks.
- the format of such inputs will vary by source and must be received, consolidated, possibly reformatted, and packaged for the Data Manager 920.
- User inputs may consist of simple requests for activation of TNSS devices 934 to status and information concerning the User's 932 situation or needs.
- TNSS devices 934 will provide signaling data that may consist of voltage readings, TNSS 934 status data, responses to control program inquiries, and other signals.
- the Communications Controller 930 is also responsible for sending data and control requests to the plurality of TNSS devices 934.
- 3rd party applications 936 can send data, requests, or instructions for the Master Control Program 910 or User 932 via Internet or cellular networks.
- the Communications Controller 930 is also responsible for communications via the cloud where various software applications reside.
- the Data Manager (DM) 920 has primary responsibility for the storage and movement of data to and from the Communications Controller 930, Sensors 938, Actuators 940, and the Master Control Program 910.
- the DM 920 has the capability to analyze and correlate any of the data under its control. It provides logic to select and activate nerves. Examples of such operations upon the data include: statistical analysis and trend identification; machine learning algorithms; signature analysis and pattern recognition, correlations among the data within the Data Warehouse 926, the Therapy Library 922, the Tissue Models 924, and the Electrode Placement Models 928, and other operations.
- the Data Warehouse (DW) 926 is where incoming data is stored
- this data can be real-time measurements from TNSS devices 934 or from Sensors (938), data streams from the Internet, or control and instructional data from various sources.
- the DM 920 will analyze data, as specified above, that is held in the DW 926 and cause actions, including the export of data, under MCP 910 control. Certain decision making processes implemented by the DM 920 will identify data patterns both in time, frequency, and spatial domains and store them as signatures for reference by other programs. Techniques like EMG, even multi- electrode EMG, gather a lot of data that is the sum of hundreds to thousands of individual motor units and the normal procedure is to perform complex decomposition analysis on the total signal to attempt to tease out individual motor units and their behavior. The DM 920 will perform big data analysis over the total signal and recognize patterns that relate to specific actions or even individual nerves or motor units. This analysis can be performed over data gathered in time from an individual, or over a population of TNSS Users.
- the Therapy Library 922 contains various control regimens for the TNSS devices 934.
- Regimens specify the parameters and patterns of pulses to be applied by the TNSS devices 934.
- the width and amplitude of individual pulses may be specified to stimulate nerve axons of a particular size selectively without
- the frequency of pulses applied may be specified to modulate some reflexes selectively without modulating other reflexes.
- Tissue Models 924 are specific to the electrical properties of particular body locations where TNSS devices 934 may be placed. As noted previously, electric fields for production of action potentials will be affected by the different electrical properties of the various tissues that they encounter. Tissue Models 924 are combined with regimens from the Therapy Library 922 and Electrode Placement Models 928 to produce desired actions. Tissue Models 924 may be developed by MRI, Ultrasound or other imaging or measurement of tissue of a body or particular part of a body. This may be accomplished for a particular User 932 and/or based upon a body norm.
- One such example embodiment of a desired action is the use of a Tissue Model 924 together with a particular Electrode Placement Model 928 to determine how to focus the electric field from electrodes on the surface of the body on a specific deep location corresponding to the pudendal nerve in order to stimulate that nerve selectively to reduce incontinence of urine.
- Other example embodiments of desired actions may occur when a Tissue Model 924 in combination with regimens from the Therapy Library 22 and
- Electrode Placement Models 928 produce an electric field that stimulates a sacral nerve. Many other embodiments of desired actions follow for the stimulation of other nerves.
- Electrode Placement Models 928 specify electrode configurations that the TNSS devices 934 may apply and activate in particular locations of the body.
- a TNSS device 934 may have multiple electrodes and the Electrode Placement Model 928 specifies where these electrodes should be placed on the body and which of these electrodes should be active in order to stimulate a specific structure selectively without stimulating other structures, or to focus an electric field on a deep structure.
- An example embodiment of an electrode configuration is a 4 by 4 set of electrodes within a larger array of multiple electrodes, such as an 8 by 8 array. This 4 by 4 set of electrodes may be specified anywhere within the larger array such as the upper right corner of the 8 by 8 array.
- Electrode configurations may be circular electrodes that may even consist of concentric circular electrodes.
- the TNSS device 934 may contain a wide range of multiple electrodes of which the Electrode Placement Models 928 will specify which subset will be activated. These Electrode Placement Models 928 complement the regimens in the Therapy Library 922 and the Tissue Models 924 and are used together with these other data components to control the electric fields and their interactions with nerves, muscles, tissues and other organs.
- Other examples may include TNSS devices 934 having merely one or two electrodes, such as but not limited to those utilizing a closed circuit.
- Independent sensors 938 and actuators 940 can be part of the TNSS system. Its functions can complement the electrical stimulation and electrical feedback that the TNSS devices 934 provide.
- An example of such a sensor 938 and actuator 940 include, but are not limited to, an ultrasonic actuator and an ultrasonic receiver that can provide real-time image data of nerves, muscles, bones, and other tissues. Other examples include electrical sensors that detect signals from stimulated tissues or muscles.
- the Sensor/ Actuator Control module 950 provides the ability to control both the actuation and pickup of such signals, all under control of the MCP 910.
- the MCP 910 is also responsible for supervising the various Application Program Interfaces (APIs) that will be made available for 3rd party developers.
- APIs Application Program Interfaces
- Another group of healthcare professionals may desire access to the Therapy Library 922 and Tissue Models 924 to construct better regimens for addressing specific diseases or disabilities. In each case a different specific API 914 may be appropriate.
- the MCP 910 is responsible for many software functions of the TNSS system including system maintenance, debugging and troubleshooting functions, resource and device management, data preparation, analysis, and communications to external devices or programs that exist on the smart phone or in the cloud, and other functions. However, one of its primary functions is to serve as a global request handler taking inputs from devices handled by the Communications
- MCP High Level Master Control Program
- the Request Handler (RH) 960 accepts inputs from the User 932, TNSS devices 934, 3rd party apps 936, sensors 938 and other sources. It determines the type of request and dispatches the appropriate response as set forth in the following paragraphs.
- the RH 960 will determine which of the plurality of User Requests 961 is present such as: activation; display status, deactivation, or data input, e.g. specific User condition. Shown in Figure 9B is the RH's 960 response to an activation request. As shown in block 962, RH 960 will access the Therapy Library 922 and cause the appropriate regimen to be sent to the correct TNSS 934 for execution, as shown at block 964 labeled "Action.”
- TNSS/Sensor Inputs The RH 960 will perform data analysis over TNSS 934 or Sensor inputs 965. As shown at block 966, it employs data analysis, which may include techniques ranging from DSP decision making processes, image processing algorithms, statistical analysis and other algorithms to analyze the inputs. In Figure 9B two such analysis results are shown; conditions which cause a User Alarm 970 to be generated and conditions which create an Adaptive Action 980 such as causing a control feedback loop for specific TNSS 934 functions, which of course can iteratively generate further TNSS 934 or Sensor inputs 965 in a closed feedback loop.
- data analysis may include techniques ranging from DSP decision making processes, image processing algorithms, statistical analysis and other algorithms to analyze the inputs.
- FIG 9B two such analysis results are shown; conditions which cause a User Alarm 970 to be generated and conditions which create an Adaptive Action 980 such as causing a control feedback loop for specific TNSS 934 functions, which of course can iteratively generate further TNSS 934 or
- 3rd Party Apps can communicate with the MCP 910, both sending and receiving communications.
- a typical communication would be to send informational data or commands to a TNSS 934.
- the RH 960 will analyze the incoming application data, as shown at block 972.
- Figure 9B shows two such actions that result.
- One action, shown at block 974 would be the presentation of the application data, possibly reformatted, to the User 932 through the MCP User Interface 912.
- Another result would be to perform a User 932 permitted action, as shown at 976, such as requesting a regimen from the Therapy Library 922.
- the TNSS has one or more electronic circuits or chips 1000 that perform the functions of:
- TNSS interfaces to transducers 1014 to transmit signals to the tissue or to receive signals from the tissue.
- One arrangement is to integrate a wide variety of these functions into an SOC, system on chip 1000.
- a control unit 1002 for data processing, communications, transducer interface and storage and one or more stimulators 1004 and sensors 1006 that are connected to electrodes 1008.
- An antenna 1010 is incorporated for external communications by the control unit.
- an internal power supply 1012 which may be, for example, a battery.
- An external power supply is another variation of the chip configuration. It may be necessary to include more than one chip to accommodate a wide range of voltages for data processing and stimulation. Electronic circuits and chips will communicate with each other via conductive tracks within the device capable of transferring data and/or power.
- the TNSS interprets a data stream from the control device, such as that shown in Figure 9A, to separate out message headers and delimiters from control instructions.
- control instructions contain information such as voltage level and pulse pattern.
- the TNSS activates the stimulator 1004 to generate a stimulation signal to the electrodes 1008 placed on the tissue according to the control instructions.
- the TNSS activates a transducer 1014 to send a signal to the tissue.
- control instructions cause information such as voltage level and pulse pattern to be retrieved from a library stored in the TNSS.
- the TNSS receives sensory signals from the tissue and translates them to a data stream that is recognized by the control device, such as the example in Figure 9A.
- Sensory signals include electrical, mechanical, acoustic, optical and chemical signals among others.
- Sensory signals come to the TNSS through the electrodes 1008 or from other inputs originating from mechanical, acoustic, optical, or chemical transducers.
- an electrical signal from the tissue is introduced to the TNSS through the electrodes 1008, is converted from an analog signal to a digital signal and then inserted into a data stream that is sent through the antenna 1010 to the control device.
- an acoustic signal is received by a transducer 1014 in the TNSS, converted from an analog signal to a digital signal and then inserted into a data stream that is sent through the antenna 1010 to the control device.
- sensory signals from the tissue are directly interfaced to the control device for processing.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
Abstract
L'invention concerne un appareil, un système et un procédé pour l'activation sélective d'un ou de plusieurs nerfs cibles d'un mammifère par un champ électrique, comprenant un timbre dermique de stimulation nerveuse topique et sans fil comportant une ou plusieurs électrodes conçues pour fournir une stimulation électrique à un ou plusieurs nerfs cibles, et un dispositif de commande conçu pour recevoir une ou plusieurs entrées utilisateur et un système de communication sans fil du timbre dermique de stimulation nerveuse topique, et conçu pour envoyer une ou plusieurs requêtes de commande au timbre dermique de stimulation nerveuse topique. Le dispositif de commande est conçu pour déterminer un modèle d'activation pour les électrodes du timbre dermique afin d'appliquer de manière sélective le champ électrique sur le nerf cible en modelant le champ électrique dans un volume de tissu à proximité du nerf cible par le modèle d'activation des électrodes, et le timbre dermique étant conçu pour activer les électrodes en fonction du modèle d'activation spécifié.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562115607P | 2015-02-12 | 2015-02-12 | |
US62/115,607 | 2015-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016130835A1 true WO2016130835A1 (fr) | 2016-08-18 |
Family
ID=56615732
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2016/017597 WO2016130835A1 (fr) | 2015-02-12 | 2016-02-11 | Appareil, système et procédé de stimulation nerveuse sélective et non invasive des mammifères et des humains |
PCT/US2016/018699 WO2016134270A1 (fr) | 2015-02-12 | 2016-02-19 | Neurostimulateur topique et capteur pour le contrôle de la vessie |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2016/018699 WO2016134270A1 (fr) | 2015-02-12 | 2016-02-19 | Neurostimulateur topique et capteur pour le contrôle de la vessie |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2016130835A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110997058A (zh) * | 2017-06-28 | 2020-04-10 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置和方法及其用途 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10363414B1 (en) | 2018-04-12 | 2019-07-30 | Feinstein Patents, Llc | Combined bladder scanner and (functional) interferential electrical stimulation device |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4989605A (en) * | 1989-03-31 | 1991-02-05 | Joel Rossen | Transcutaneous electrical nerve stimulation (TENS) device |
US20090132018A1 (en) * | 2007-11-16 | 2009-05-21 | Ethicon, Inc. | Nerve Stimulation Patches And Methods For Stimulating Selected Nerves |
US20120259239A1 (en) * | 2009-07-29 | 2012-10-11 | Fabrice Chenaux | Neurophysiological stimulation system and methods with wireless communication |
US20130231725A1 (en) * | 2011-08-30 | 2013-09-05 | Michael Williams | Peripheral Afferent Nerve Stimulation for Treatment of Epilepsy |
US20130304175A1 (en) * | 2012-05-10 | 2013-11-14 | Ethicon Endo-Surgery, Inc. | Device and Method for Self-Positioning of a Stimulation Device to Activate Brown Adipose Tissue Depot in a Supraclavicular Fossa Region |
US20140194760A1 (en) * | 2013-01-07 | 2014-07-10 | David E. Albert | Methods and systems for electrode placement |
WO2014113813A1 (fr) * | 2013-01-21 | 2014-07-24 | Cala Health, Inc. | Dispositifs et procédés pour contrôler les tremblements |
US20140316507A1 (en) * | 2008-01-07 | 2014-10-23 | Empi Inc. | Systems and methods for therapeutic electrical stimulation |
WO2014194200A1 (fr) * | 2013-05-30 | 2014-12-04 | Creasey Graham H | Stimulation neurologique topique |
US20140371802A1 (en) * | 2013-06-17 | 2014-12-18 | Adi Mashiach | Flexible Control Housing for Disposable Patch |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1675501B1 (fr) * | 2003-09-12 | 2013-09-04 | Or-Nim Medical Ltd. | Methode et appareil de surveillance non invasive d'une region d'interet dans le corps d'un individu |
IL158379A0 (en) * | 2003-10-13 | 2004-05-12 | Volurine Israel Ltd | Non invasive bladder distension monitoring apparatus to prevent enuresis, and method of operation therefor |
US7647112B2 (en) * | 2004-02-11 | 2010-01-12 | Ethicon, Inc. | System and method for selectively stimulating different body parts |
US8691877B2 (en) * | 2004-10-15 | 2014-04-08 | Palo Alto Investors | Methods and compositions for treating a disease condition in a subject |
IL172754A0 (en) * | 2005-12-22 | 2006-04-10 | Menashe Shahar | Urethral blockage diagnosis |
US9339641B2 (en) * | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
US9174045B2 (en) * | 2009-03-20 | 2015-11-03 | ElectroCore, LLC | Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence |
EP2509508A4 (fr) * | 2009-12-08 | 2015-11-18 | Aum Cardiovascular Inc | Systèmes et procédés destinés à détecter une maladie cardiovasculaire |
-
2016
- 2016-02-11 WO PCT/US2016/017597 patent/WO2016130835A1/fr active Application Filing
- 2016-02-19 WO PCT/US2016/018699 patent/WO2016134270A1/fr active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4989605A (en) * | 1989-03-31 | 1991-02-05 | Joel Rossen | Transcutaneous electrical nerve stimulation (TENS) device |
US20090132018A1 (en) * | 2007-11-16 | 2009-05-21 | Ethicon, Inc. | Nerve Stimulation Patches And Methods For Stimulating Selected Nerves |
US20140316507A1 (en) * | 2008-01-07 | 2014-10-23 | Empi Inc. | Systems and methods for therapeutic electrical stimulation |
US20120259239A1 (en) * | 2009-07-29 | 2012-10-11 | Fabrice Chenaux | Neurophysiological stimulation system and methods with wireless communication |
US20130231725A1 (en) * | 2011-08-30 | 2013-09-05 | Michael Williams | Peripheral Afferent Nerve Stimulation for Treatment of Epilepsy |
US20130304175A1 (en) * | 2012-05-10 | 2013-11-14 | Ethicon Endo-Surgery, Inc. | Device and Method for Self-Positioning of a Stimulation Device to Activate Brown Adipose Tissue Depot in a Supraclavicular Fossa Region |
US20140194760A1 (en) * | 2013-01-07 | 2014-07-10 | David E. Albert | Methods and systems for electrode placement |
WO2014113813A1 (fr) * | 2013-01-21 | 2014-07-24 | Cala Health, Inc. | Dispositifs et procédés pour contrôler les tremblements |
WO2014194200A1 (fr) * | 2013-05-30 | 2014-12-04 | Creasey Graham H | Stimulation neurologique topique |
US20140371802A1 (en) * | 2013-06-17 | 2014-12-18 | Adi Mashiach | Flexible Control Housing for Disposable Patch |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110997058A (zh) * | 2017-06-28 | 2020-04-10 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置和方法及其用途 |
CN110997058B (zh) * | 2017-06-28 | 2023-10-27 | 技术研究与创新基金会 | 用于活性剂的受控制的和受监视的经皮给药的装置 |
Also Published As
Publication number | Publication date |
---|---|
WO2016134270A1 (fr) | 2016-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11077301B2 (en) | Topical nerve stimulator and sensor for bladder control | |
US20160243358A1 (en) | Topical Nerve Stimulator and Sensor for Control of Autonomic Function | |
US11779761B2 (en) | Non-invasive nerve stimulation | |
CN103002947B (zh) | 刺激电极选择 | |
WO2016134273A1 (fr) | Stimulateur topique de nerf et capteur pour la gestion de la douleur | |
WO2016137926A1 (fr) | Neurostimulateur topique et capteur pour la commande d'une fonction autonome | |
US20160235982A1 (en) | Non-Invasive Selective Human and Mammalian Nerve Stimulation System and Method | |
US10517791B2 (en) | High-resolution, selective and self-optimizing haptic and electrotactile display and methods of use | |
Kilpatrick | Wilson-cowan model | |
CN112105416A (zh) | 非侵入性慢性疼痛疗法的设备,系统和方法 | |
US20200376266A1 (en) | Non-Invasive Nerve Stimulation to Delay Urination | |
WO2024021960A1 (fr) | Générateur d'impulsions, système médical et support de stockage lisible par ordinateur | |
Shah et al. | Computational challenges and opportunities for a bi-directional artificial retina | |
Abougarair et al. | Implementation of a brain-computer interface for robotic arm control | |
US20140135642A1 (en) | Nature-inspired signal processing | |
KR20190034867A (ko) | 신경모방 자극 장치 및 그 방법 | |
WO2016130835A1 (fr) | Appareil, système et procédé de stimulation nerveuse sélective et non invasive des mammifères et des humains | |
US20160243356A1 (en) | Topical Nerve Stimulator and Sensor for Sexual Function | |
US20170239471A1 (en) | Topical Nerve Stimulator and Sensor for Pain Management | |
WO2016134296A1 (fr) | Stimulateur de nerf topique et capteur pour fonction sexuelle | |
Rattay et al. | Neuron modeling | |
CA3092366C (fr) | Stimulation nerveuse non invasive | |
WO2023185410A1 (fr) | Procédé d'identification d'imagerie pour fil d'électrode de stimulation, et appareil associé | |
US11717683B2 (en) | Non-invasive nerve stimulation | |
US20200297992A1 (en) | Primary Dysmenorrhea Pain Reduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16749900 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16749900 Country of ref document: EP Kind code of ref document: A1 |